ClinicalTrials.Veeva

Menu

SV2A in Older Adults

Yale University logo

Yale University

Status and phase

Enrolling
Phase 2
Phase 1

Conditions

Cannabis Use

Treatments

Drug: [11C]UCB-J PET

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05465538
2000032183

Details and patient eligibility

About

The aim of the study is to examine the effect of cannabis use on brain synaptic density among older adults using [11C]UCB-J PET imaging.

Enrollment

24 estimated patients

Sex

All

Ages

50+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Able to provide informed consent
  • Male or female, aged ≥50 years
  • No history of significant medical or neurological disease
  • BMI ≤ 50
  • If woman of childbearing potential, must agree to use an acceptable method of birth control, as determined by the principal investigator, for the duration of the study and up to one month after completion of PET scans

Exclusion criteria

  • Women with a positive pregnancy test or women who are lactating
  • Have had exposure to ionizing radiation that in combination with the study tracer would result in a cumulative exposure that exceeds recommended exposure limits;
  • History of a bleeding disorder or are currently taking anticoagulants
  • Subjects who have donated blood within 8 weeks of the present study

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

24 participants in 2 patient groups

Cannabis using older adults
Other group
Description:
Subjects undergo a single PET scan using \[11C\]UCB-J
Treatment:
Drug: [11C]UCB-J PET
Healthy controls
Other group
Description:
Subjects undergo a single PET scan using \[11C\]UCB-J
Treatment:
Drug: [11C]UCB-J PET

Trial contacts and locations

1

Loading...

Central trial contact

Angerlyk Frytz, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems